Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
Published
Related content
- Understanding the changes to MDMA and psilocybin accessFind out about the safety controls that will be in place before authorised psychiatrists can prescribe psychedelic medicines to people with specific mental health conditions.
- TGA grants provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir)The TGA has granted provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir).
- Pfizer's COVID-19 vaccine (COMIRNATY) provisionally approved for use in individuals 5 years and overThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use in individuals 5 years and older.